Global finance for fighting HIV in Africa exists on shaky grounds — much of it at the whims of American politicians who have the power to sever support for the U.S. President's Emergency Plan For AIDS Relief, which has invested billions into the continent’s HIV response.
But a group of experts from across Africa are working to craft a road map for a new kind of HIV response — drawing on the diversity of the continent and its resources, including human capital.
The two co-chairs of the African-led HIV Control Working Group gave Devex a preview of the shape it’s taking. This includes Dr. Magda Robalo, president and co-founder of the Institute for Global Health and Development of Guinea-Bissau, and Dr. Izukanji Sikazwe, chief executive officer of the Centre for Infectious Disease Research in Zambia.
About the author
Sara Jervingsarajerving
Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.
